Eurofins Scientific

Eurofins is an international group of laboratories headquartered in Luxembourg, providing testing and support services to the pharmaceutical, food, environmental, agriscience and consumer products industries[1][2] and to governments.

Eurofins Scientific SE
TypePublic
Euronext: ERF
CAC 40
IndustryTesting and Laboratory analysis
Founded1987[1]
FounderGilles Martin[1]
HeadquartersLuxembourg
RevenueEUR 5.4 billion (2021)
Number of employees
55,000 (2021)
Websitewww.eurofins.com

Eurofins Group has an international network of more than 900 laboratories across 50 countries and a portfolio of over 200,000 validated analytical methods for characterising the safety, identity, purity, composition, authenticity and origin of products and biological substances. Eurofins also provides clinical diagnostic testing services and in-vitro diagnostic products. Through research and development, in-licensing and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical sciences.

History

Eurofins Scientific was founded in 1987 with 4 employees, when Gilles Martin purchased the rights to the SNIF-NMR technology from the University of Nantes, a patented analytical method used to verify the origin and purity of several types of food and beverages and identify sophisticated fraud not detectable by other methods. This technology had been researched and developed by his own parents, who were professors at the university. Eurofins derived the "fins" of its name from the French version of SNIF-NMR: Fractionnement Isotopique Naturel Spécifique par Résonance Magnétique Nucléaire or FINS-RMN. During this start up period (1987 to 1997), the SNIF-NMR® patent was registered and approved in the US and broadened to apply to a wider range of products than the original wine test, such as fruit juices and other non-alcoholic beverages. The strategy was then formulated to develop the offering in-house and to expand the range of tests provided to customers.

From 1997, the focus for Eurofins was to buy the very best labs with unique technologies and know how with the potential for global recognition. Additionally the Group expanded to eight new countries and grew to include over 50 laboratory sites. Leading positions were built up in core markets (Food, Pharma and Environment) and also key segments such as genomic information and contaminants testing. This in turn enabled the group access to new, top-tier clients in the pharma and retailing sectors. This was funded firstly with the IPO in Paris in 1997 and then the secondary listing in Frankfurt in 2000.

From 2002, Eurofins started developing the infrastructure to support the business, including a unified IT platform.

Recent news

On 1 July 2014, Eurofins purchased Viracor-IBT Laboratories from Ampersand Capital Partners for $255 million. The company will continue to be known as ViraCor-IBT.[3]

In May 2015, Eurofins acquired QC Laboratories in the US and Experchems in Canada as part of its North American expansion strategy.[4]

In June 2015, Eurofins announced the acquisition of Biomnis in France for 220 million euros.[5] In September 2017, Eurofins Scientific announced to acquire EAG Laboratories (Evans Analytical Group), a scientific services company that serves technology and life-science-related industries.[6] On 5 March 2018, the Pennsylvania Department of Environmental Protection announced to collect a $600,000 penalty from Eurofins QC, LLC (Eurofins QC in Montgomery County, Pennsylvania) for falsifying whole effluent toxicity test (WETT) results.[7]

Eurofins purchased Nanolab Technologies Inc, a service lab for the silicon valley industry, on 2 August 2018.[8]

Eurofins acquired MET Labs on 11 January 2018, which enabled them to have a Nationally Recognized Test Laboratory as established by OHSA.[9] At the end of 2018, a deal was finalized between Eurofins and the JSTI Group for the acquisition of TestAmerica Environmental Services, LLC, adding 24 laboratories and 40 service centers to the Eurofins environmental testing network.[10]

On 3 June 2019, Eurofins reported that some of its IT systems were infected with ransomware and many servers and systems were taken offline.[11] Eurofins paid the ransom after heavy disruption of their services. Court hearings were postponed as the forensics division was unable to take new samples.[12]

In 2020, Eurofins created the capacity to help over 20 million patients monthly who may have been impacted by COVID-19 with testing products and services and supporting healthcare professionals working on the front line. Eurofins established PCR testing capabilities and has carried out over 25 million tests in its own laboratories, is supporting the development of a number of vaccines and has established its SAFER@WORK™ testing, monitoring and consulting programmes. [13]

Eurofins acquired Japanese genetics analysis company GeneTech, a leader in the specialist field of non-invasive pre-natal testing in August 2020.[14]

In September 2020, Eurofins announced the acquisition of SunDream Group in Taiwan, which specialises in environmental analyses. The acquisition allowed Eurofins to become the leading player in the environmental analyst market in the country.[15]

In February 2021, Eurofins acquired Beacon Discovery, a California based company specialising in drug research. The group focuses on “G protein coupled receptors,” a major class of proteins in human cells, on which many molecules can act.[16]

Eurofins announced the acquisition of the American DNA Diagnostics Centers (DDC), a group specializing in genetic testing, in June 2021.[17]

Product authentication

The company has developed an exclusive method of food analysis, testing and authentication that has thwarted the counterfeiting of food goods, and also cigars.[1][18] The company's testing can also detect food contaminants.[1]

See also

References

  1. (in French) Le réseau, botte secrète d'Eurofins, L'Usine nouvelle n° 2965, 26 May 2005
  2. (in German) Eurofins. Der Testsieger. Warum der Labormulti von Skandalen in aller Welt und neuen EU-Verordnungen profitiert, Focus, 15 October 2008
  3. Ampersand Capital Partners. "Ampersand Sells ViraCor-IBT To Eurofins For $255 Million". PR Newswire. Retrieved 8 November 2017.
  4. Joe Whitworth (7 May 2015). "Eurofins acquired US and Canadian firms to push into Americas market". FoodQualityNews.com. Retrieved 8 May 2015.
  5. "Eurofins to acquire the Biomnis Group".
  6. Editors, Pharmaceutical Technology. "Eurofins Scientific to Acquire EAG Labs". www.pharmtech.com. Retrieved 28 September 2017.CS1 maint: extra text: authors list (link)
  7. Pennsylvania Pressroom, Official News for Pennsylvania State Agencies. "DEP Sanctions Eurofins QC Lab for Water Testing Violations". www.media.pa.gov. Retrieved 12 March 2018.
  8. "Eurofins to expand new Materials and Engineering Science verticals with the acquisition of Nanolab Technologies, cementing presence in high-tech industries". Eurofins Scientific. Retrieved 8 August 2018.
  9. "MET Labs NRTL recognition". OHSA. Retrieved 1 March 2019.
  10. "Eurofins Acquires TestAmerica". ENVSTD. 4 December 2018. Retrieved 14 July 2020.
  11. "Eurofins Genomics live updates". Retrieved 4 June 2019.
  12. Danny Shaw: Eurofins Scientific: Forensic services firm paid ransom after cyber-attack, BBC
  13. Cox, James. "Irish company announces 12-hour PCR test results". breakingnews.ie. Retrieved 14 December 2021.
  14. "French group Eurofins signs deal to buy Japanese company GeneTech". Reuters. 2020-08-07. Retrieved 2021-12-02.
  15. "Eurofins se renforce en Asie-Pacifique avec une acquisition à Taïwan". LEFIGARO (in French). 2020-09-04. Retrieved 2021-12-02.
  16. "Pharmacie: Eurofins rachète un spécialiste de la découverte de médicaments". LEFIGARO (in French). 2021-02-18. Retrieved 2021-12-02.
  17. "Eurofins va acquérir le spécialiste des tests génétiques DNA Diagnostic Centers". fr.advfn.com. Retrieved 2021-12-02.
  18. (in French) Eurofins trace son chemin en traquant les tricheurs, L'Usine nouvelle n° 2713, 9 December 1999
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.